# Thoracic surgeons’ practice and attitude towards surgical antimicrobial prophylaxis in VATS lung surgery: A survey within a large medical consortium

**Authors:** Xiaotong Gu, Yue Liu, Yanguo Liu, Jing Huang, Yi Liu, Lin Huang, Xiaohong Zhang, Rongrong Fan

PMC · DOI: 10.1371/journal.pone.0339389 · PLOS One · 2026-02-02

## TL;DR

This study surveyed thoracic surgeons in China about their use of antibiotics before and after lung surgery, finding widespread deviations from guidelines and a need for updated, patient-specific recommendations.

## Contribution

The study identifies common deviations from antimicrobial prophylaxis guidelines among thoracic surgeons in VATS lung surgery and highlights the need for multidisciplinary, patient-specific guidelines.

## Key findings

- Most surgeons administered antimicrobials preoperatively, predominantly cefuroxime within 0.5 to 1 hour before surgery.
- Postoperative antimicrobial use was common, often continuing until drainage tube removal, with frequent deviations from guidelines.
- Departmental habits and lack of patient-specific guidance in guidelines were major reasons for inconsistent SAP practices.

## Abstract

Surgical site infections (SSIs) are a significant post-surgery complication, impacting mortality, morbidity, and healthcare costs. Surgical antimicrobial prophylaxis (SAP) is pivotal in SSIs prevention. This study aimed to evaluate the current use of SAP in video-assisted thoracoscopic surgery (VATS) lung surgery in China.

A descriptive, cross-sectional survey study was conducted among thoracic surgeons within a large medical consortium in order to assess their practice and attitude about SAP. A three-section multiple-choice online questionnaire was designed and distributed via WeChat software to thoracic surgeons. The surgeons’ answers were considered consistent when they were in accordance to clinical guidelines.

89 thoracic surgeons were requested to participate in this study and their response rate was 73.03%. Preoperatively, 60.00% administered antimicrobials, predominantly within 0.5 to 1 hour before surgery, with cefuroxime as the preferred agent. Intraoperatively, 32.31% did not administer additional antimicrobials, and postoperatively, 90.77% prescribed them, often continuing until drainage tube removal. Surgeons frequently upgraded prophylaxis, especially postoperatively. Deviations from guidelines were common, particularly in postoperative SAP duration (76.92%), intraoperative redosing decisions (58.33%), and preoperative SAP administration (40.00%). Departmental habits significantly influenced SAP practices. The primary reason for inconsistencies was the absence of patient-specific considerations in the guidelines, affecting nearly half of the cases. Experienced surgeons were more likely to cite this lack of patient-specific attention as a reason for deviation.

The study underscores the need for updated, multidisciplinary guidelines for VATS lung surgery, emphasizing the importance of a collaborative approach among healthcare professionals to optimize individualized SAP.

## Linked entities

- **Chemicals:** cefuroxime (PubChem CID 5479529)

## Full-text entities

- **Genes:** IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, SH2D1A (SH2 domain containing 1A) [NCBI Gene 4068] {aka DSHP, EBVS, IMD5, LYP, MTCP1, SAP}
- **Diseases:** malnutrition (MESH:D044342), thoracic tumors (MESH:D013899), diabetes (MESH:D003920), postoperative infection complications (MESH:D011183), pneumonia (MESH:D011014), immunodeficiency (MESH:D007153), lung diseases (MESH:D008171), allergies (MESH:D004342), infective complications (MESH:D002494), liver and kidney failure (MESH:D051437), blood loss (MESH:D016063), infection (MESH:D007239), SSIs (MESH:D013530), obesity (MESH:D009765), postoperative (MESH:D019106), toxicity (MESH:D064420), bleeding (MESH:D006470), infectious (MESH:D003141), cancer (MESH:D009369), empyema (MESH:D004653), Lung cancer (MESH:D008175)
- **Chemicals:** aztreonam (MESH:D001398), penicillin (MESH:D010406), Piperacillin (MESH:D010878), cefuroxime (MESH:D002444), Tazobactam (MESH:D000078142), Sulbactam (MESH:D013407), Carbapenems (MESH:D015780), fluoroquinolones (MESH:D024841), piperacillin &amp; tazobactam (MESH:D000077725), cephalosporin (MESH:D002511), clindamycin (MESH:D002981), cefazolin (MESH:D002437), cephalosporin allergy (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12863502/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12863502/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12863502/full.md

---
Source: https://tomesphere.com/paper/PMC12863502